AI English summary of an SEC filing — figures as filed
CME Group CMECME Group held its annual meeting of shareholders on May 14, 2026, and said that as of the record date of March 16, 2026, 318,466,544 shares of Classes A and B out of 362,808,081 shares issued and outstanding were present, representing 87.78%. The company said that Class B-1, B-2, B-3, and B-4 did not reach quorum.
Key points
AI summaryCME Group held its annual meeting of shareholders on May 14, 2026, and said that as of the record date of March 16, 2026, 318,466,544 shares of Classes A and B out of 362,808,081 shares issued and outstanding were present, representing 87.78%. The company said that Class B-1, B-2, B-3, and B-4 did not reach quorum.
The company said that for each class of common stock, at least 33.3% of the issued and outstanding shares must be present to obtain quorum, and that Class B-1 through B-4 exceeded this threshold. Accordingly, the proposals under Items 4 through 8 were adjourned to a virtual meeting on June 9, 2026 at 11:00 a.m. Central Time.
CME Group said that all 14 Equity Director nominees were elected to serve until the 2027 annual meeting of shareholders. Terrence A. Duffy received 267,885,386 votes for, 26,615,419 votes against, and 459,914 abstentions, with 23,505,825 broker non-votes.
The company said the proposal to ratify the appointment of Ernst & Young LLP as the independent auditor for 2026 was approved with 291,376,905 votes for. The advisory vote on the compensation of the company's named executive officers was also approved with 259,576,112 votes for, 34,530,288 votes against, and 854,319 abstentions.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
2026 Annual Meeting Attendance and Class B Quorum Failure
CME Group held its annual meeting of shareholders on May 14, 2026, and said that as of the record date of March 16, 2026, 318,466,544 shares of Classes A and B out of 362,808,081 shares issued and outstanding were present, representing 87.78%. The company said that Class B-1, B-2, B-3, and B-4 did not reach quorum.
Source · Based on the filing body and exhibits
Adjournment of Items 4–8 to Virtual Meeting on June 9, 2026
The company said that for each class of common stock, at least 33.3% of the issued and outstanding shares must be present to obtain quorum, and that Class B-1 through B-4 exceeded this threshold. Accordingly, the proposals under Items 4 through 8 were adjourned to a virtual meeting on June 9, 2026 at 11:00 a.m. Central Time.
Source · Based on the filing body and exhibits
14 Directors Elected at Shareholders Meeting
CME Group said that all 14 Equity Director nominees were elected to serve until the 2027 annual meeting of shareholders. Terrence A. Duffy received 267,885,386 votes for, 26,615,419 votes against, and 459,914 abstentions, with 23,505,825 broker non-votes.
Source · Based on the filing body and exhibits
Auditor Appointment Approved and Executive Compensation Advisory Vote Results
The company said the proposal to ratify the appointment of Ernst & Young LLP as the independent auditor for 2026 was approved with 291,376,905 votes for. The advisory vote on the compensation of the company's named executive officers was also approved with 259,576,112 votes for, 34,530,288 votes against, and 854,319 abstentions.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…